Portage Biotech (PRTG) Short Interest Ratio & Short Volume $8.09 -0.24 (-2.88%) Closing price 05/21/2025 03:59 PM EasternExtended Trading$8.14 +0.04 (+0.56%) As of 05/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Portage Biotech Short Interest DataPortage Biotech (PRTG) has a short interest of 114,400 shares, representing 69.97% of the float (the number of shares available for trading by the public). This marks a -13.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 980,174 shares to cover all short positions.Current Short Interest114,400 sharesPrevious Short Interest131,900 sharesChange Vs. Previous Month-13.27%Dollar Volume Sold Short$1.36 millionShort Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares1,049,000 sharesFloat Size163,500 sharesShort Percent of Float69.97%Today's Trading Volume20,248 sharesAverage Trading Volume980,174 sharesToday's Volume Vs. Average2% Short Selling Portage Biotech? Sign up to receive the latest short interest report for Portage Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPRTG Short Interest Over TimePRTG Days to Cover Over TimePRTG Percentage of Float Shorted Over Time Portage Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025114,400 shares $1.36 million -13.3%70.0%0.1 $11.85 4/15/2025131,900 shares $1.05 million -57.2%80.7%0.1 $7.99 3/31/2025308,400 shares $2.85 million +2,134.8%50.7%0.5 $9.25 3/15/202513,800 shares $58,098.00 -20.7%8.4%0.2 $4.21 2/28/202517,400 shares $78,474.00 +33.9%10.6%0 $4.51 2/15/202513,000 shares $59,930.00 -43.0%8.0%0 $4.61 1/31/202522,800 shares $100,548.00 +15.2%5.2%0 $4.41 1/15/202519,800 shares $78,606.00 -25.0%4.5%0 $3.97 12/31/202426,400 shares $136,488.00 +175.0%6.0%0 $5.17 12/15/20249,600 shares $28,800.00 +2.1%2.2%0 $3.00 Get the Latest News and Ratings for PRTG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter. 11/30/20249,400 shares $39,339.00 -6.9%2.2%0 $4.19 11/15/202410,100 shares $41,309.00 -30.3%2.4%0 $4.09 10/31/202414,500 shares $82,360.00 -22.9%3.4%0 $5.68 10/15/202418,800 shares $117,688.00 +6.8%4.4%0 $6.26 9/30/202417,600 shares $117,040.00 +87.2%4.2%0 $6.65 9/15/20249,400 shares $33,464.00 -80.2%2.2%0 $3.56 8/31/202447,400 shares $163,530.00 +558.3%11.2%0.1 $3.45 8/15/20247,200 shares $25,200.00 -88.1%0.1%0 $3.50 7/31/202460,600 shares $10,671.66 -75.0%0.7%0.1 $0.18 7/15/2024242,000 shares $43,560.00 +1,628.6%2.8%0.3 $0.18 6/30/202414,000 shares $2,970.80 -74.5%0.2%0 $0.21 6/15/202454,900 shares $13,725.00 -9.3%0.6%0.2 $0.25 5/31/202460,500 shares $28,973.45 +2.2%0.7%0.2 $0.48 5/15/202459,200 shares $15,134.42 +2,473.9%0.7%0.3 $0.26 4/30/20242,300 shares $559.13 -72.6%0.0%0 $0.24 4/15/20248,400 shares $2,856.00 +29.2%0.1%0.1 $0.34 3/31/20246,500 shares $3,661.45 -57.8%0.1%0.1 $0.56 3/15/202415,400 shares $8,470.00 -84.6%0.2%0.2 $0.55 2/29/2024100,200 shares $59,118.00 +902.0%1.2%1.8 $0.59 2/15/202410,000 shares $6,005.00 -9.1%0.1%0.2 $0.60 1/31/202411,000 shares $9,571.10 +44.7%0.1%0.3 $0.87 1/15/20247,600 shares $8,208.00 +16.9%0.1%0.2 $1.08 12/31/20236,500 shares $11,830.00 -63.1%0.1%0.2 $1.82 12/15/202317,600 shares $22,352.00 -25.4%0.2%0.5 $1.27 11/30/202323,600 shares $31,034.00 -56.4%0.3%0.8 $1.32 11/15/202354,100 shares $78,445.00 +4.4%0.7%2 $1.45 10/31/202351,800 shares $102,823.00 -8.3%0.6%2.3 $1.99 10/15/202356,500 shares $119,780.00 +4.2%0.7%2.5 $2.12 9/30/202354,200 shares $113,278.00 +32.2%0.7%2.9 $2.09 9/15/202341,000 shares $118,490.00 +494.2%0.5%2.9 $2.89Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 8/31/20236,900 shares $17,664.00 -27.4%0.1%0.5 $2.56 8/15/20239,500 shares $22,800.00 +30.1%0.1%0.7 $2.40 7/31/20237,300 shares $23,506.00 +1.4%0.1%0.5 $3.22 7/15/20237,200 shares $24,408.00 +22.0%0.1%0.5 $3.39 6/30/20235,900 shares $20,591.00 -24.4%0.1%0.4 $3.49 6/15/20237,800 shares $28,860.00 -1.3%0.1%0.4 $3.70 5/31/20237,900 shares $27,492.00 -75.8%0.1%0.3 $3.48 5/15/202332,600 shares $104,646.00 -10.4%0.4%1.3 $3.21 4/30/202336,400 shares $121,576.00 -34.8%0.5%1.3 $3.34 4/15/202355,800 shares $175,770.00 +5.5%0.7%1.7 $3.15 3/31/202352,900 shares $163,461.00 +32.6%0.7%1.5 $3.09 3/15/202339,900 shares $119,700.00 -6.8%0.5%1.1 $3.00 2/28/202342,800 shares $163,496.00 -9.1%0.5%1.1 $3.82 2/15/202347,100 shares $198,762.00 -3.1%0.4%1.3 $4.22 1/31/202348,600 shares $250,290.00 +7.5%0.4%1.4 $5.15 1/15/202345,200 shares $246,150.16 -11.2%0.3%1.7 $5.45 12/30/202250,900 shares $269,261.00 +7.4%0.4%2.1 $5.29 12/15/202247,400 shares $237,000.00 -0.8%0.4%2.3 $5.00 11/30/202247,800 shares $281,064.00 +2.6%0.4%2.6 $5.88 11/15/202246,600 shares $280,066.00 +2.4%0.4%3.2 $6.01 10/31/202245,500 shares $298,935.00 -23.1%0.3%3.2 $6.57 10/15/202259,200 shares $400,192.00 +11.1%0.9%3.9 $6.76 9/30/202253,300 shares $363,506.00 +1.0%0.8%3.3 $6.82 9/15/202252,800 shares $414,480.00 -23.6%0.8%2 $7.85 8/31/202269,100 shares $532,761.00 +0.4%1.4%2.3 $7.71 8/15/202268,800 shares $580,672.00 -12.1%1.4%1.9 $8.44 7/31/202278,300 shares $792,396.00 +9.2%1.5%1.8 $10.12 7/15/202271,700 shares $646,017.00 -6.0%1.4%1.6 $9.01 6/30/202276,300 shares $532,574.00 -56.2%1.5%1.7 $6.98 6/15/2022174,100 shares $1.55 million -11.4%3.4%3.9 $8.93 5/31/2022196,500 shares $1.97 million -20.7%3.9%5.4 $10.00 5/15/2022247,900 shares $1.54 million +6.3%4.9%6.8 $6.20 4/30/2022233,200 shares $1.29 million +13.6%4.6%8.2 $5.54 4/15/2022205,300 shares $1.31 million +3.5%4.0%7.7 $6.39 3/31/2022198,400 shares $1.30 million +5.4%3.9%8.1 $6.57 3/15/2022188,200 shares $1.41 million +3.9%3.7%8.1 $7.51 2/28/2022181,100 shares $1.44 million +11.5%3.6%7.8 $7.95 2/15/2022162,400 shares $1.44 million +9.5%3.2%6.7 $8.84 1/31/2022148,300 shares $1.29 million +1.4%2.9%6 $8.68 1/15/2022146,200 shares $1.54 million +2.2%2.9%5.6 $10.54 12/31/2021143,100 shares $1.54 million +12.8%2.9%5.7 $10.73 12/15/2021126,900 shares $1.54 million +3.9%2.6%5.2 $12.13 11/30/2021122,200 shares $1.80 million -9.3%2.5%4.5 $14.73 11/15/2021134,700 shares $2.94 million -9.5%2.8%5.6 $21.86 10/29/2021148,800 shares $3.04 million +3.1%3.0%6.1 $20.40 10/15/2021144,400 shares $3.00 million -8.5%3.0%5.4 $20.79 9/30/2021157,800 shares $3.21 million +0.9%3.2%4.8 $20.32 9/15/2021156,400 shares $2.97 million -10.1%3.2%2.2 $18.97 8/31/2021174,000 shares $3.53 million -0.7%3.6%2.4 $20.31 8/13/2021175,200 shares $3.03 million No Change3.6%2.4 $17.32Washington Is Broke—and Eyeing Your Savings Next (Ad)Washington is running out of money…And guess where they'll look next? When governments go broke, they take from the people. It's happened before, and it's happening again. The Department of Justice just admitted that cash isn't legally YOUR property.Get your free guide now by clicking here >> PRTG Short Interest - Frequently Asked Questions What is Portage Biotech's current short interest? Short interest is the volume of Portage Biotech shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 114,400 shares of PRTG short. 69.97% of Portage Biotech's shares are currently sold short. Learn More on Portage Biotech's current short interest. What is a good short interest percentage for Portage Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 69.97% of Portage Biotech's floating shares are currently sold short. Is Portage Biotech's short interest increasing or decreasing? Portage Biotech saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 114,400 shares, a decrease of 13.3% from the previous total of 131,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Portage Biotech's float size? Portage Biotech currently has issued a total of 1,049,000 shares. Some of Portage Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Portage Biotech currently has a public float of 163,500 shares. How does Portage Biotech's short interest compare to its competitors? 69.97% of Portage Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Portage Biotech: Kezar Life Sciences, Inc. (1.11%), FibroGen, Inc. (3.72%), Marinus Pharmaceuticals, Inc. (3.95%), MiNK Therapeutics, Inc. (2.29%), Allakos Inc. (0.37%), Scilex Holding (5.79%), CalciMedica, Inc. (1.09%), Surrozen, Inc. (0.90%), Generation Bio Co. (2.47%), Cadrenal Therapeutics, Inc. (1.76%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Portage Biotech stock? Short selling PRTG is an investing strategy that aims to generate trading profit from Portage Biotech as its price is falling. PRTG shares are trading down $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Portage Biotech? A short squeeze for Portage Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRTG, which in turn drives the price of the stock up even further. How often is Portage Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRTG, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies KZR Short Squeeze FGEN Short Squeeze MRNS Short Squeeze INKT Short Squeeze ALLK Short Squeeze SCLX Short Squeeze CALC Short Squeeze SRZN Short Squeeze GBIO Short Squeeze CVKD Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PRTG) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PRTG Stock Free PRTG Stock Alerts